tau 284 has been researched along with olopatadine hydrochloride in 6 studies
| Studies (tau 284) | Trials (tau 284) | Recent Studies (post-2010) (tau 284) | Studies (olopatadine hydrochloride) | Trials (olopatadine hydrochloride) | Recent Studies (post-2010) (olopatadine hydrochloride) |
|---|---|---|---|---|---|
| 52 | 18 | 21 | 317 | 103 | 111 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Iizuka, H; Ishida-Yamamoto, A; Takahashi, H | 1 |
| Fukui, H; Izumi, N; Mizuguchi, H; Ogino, S; Umehara, H | 1 |
| Kanamitsu, K; Kusuhara, H; Nagaya, Y; Nozaki, Y; Sugiyama, Y | 1 |
| Babu, M; Dudeja, I; Dudeja, L; Janakiraman, A; Sane, K | 1 |
| Fordjuor, G; Kim, SI; Lee, JE; Lee, JH; Lee, JS; Park, CY | 1 |
| Ayyappanavar, S; Gangasagara, SB; Jayanthi, CR; Kumar, K; Mittal, P; Preethi, B; Rathod, BLS; Sridhar, S | 1 |
3 trial(s) available for tau 284 and olopatadine hydrochloride
| Article | Year |
|---|---|
Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Topics: Adult; Cetirizine; Cross-Over Studies; Dermatitis, Atopic; Dibenzoxepins; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Iontophoresis; Male; Olopatadine Hydrochloride; Piperidines; Psychomotor Performance; Pyridines; Sleep Stages; Terfenadine | 2004 |
Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzazepines; Child; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Histamine H1 Antagonists; Humans; Imidazoles; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Piperidines; Prospective Studies; Pyridines; Single-Blind Method; Treatment Outcome; Young Adult | 2019 |
Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis.
Topics: Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Double-Blind Method; Humans; Imidazoles; Olopatadine Hydrochloride; Ophthalmic Solutions; Piperidines; Prospective Studies; Pyridines; Treatment Outcome | 2021 |
3 other study(ies) available for tau 284 and olopatadine hydrochloride
| Article | Year |
|---|---|
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniramine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Imidazoles; Japan; Male; Middle Aged; Olopatadine Hydrochloride; Pain Measurement; Piperidines; Population Surveillance; Psychomotor Performance; Pyridines; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sleep Stages; Surveys and Questionnaires; Terfenadine; Urticaria | 2008 |
Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data.
Topics: Animals; Brain; Central Nervous System; Diphenhydramine; Histamine H1 Antagonists; Humans; Ketotifen; Macaca fascicularis; Male; Mice; Mice, Inbred Strains; Olopatadine Hydrochloride; Piperidines; Positron-Emission Tomography; Pyridines; Receptors, Histamine H1; Time Factors | 2017 |
Comparison of cytotoxicities and anti-allergic effects of topical ocular dual-action anti-allergic agents.
Topics: Anti-Allergic Agents; Benzazepines; Cell Survival; Cells, Cultured; Conjunctiva; Cornea; Epithelial Cells; Humans; Imidazoles; Olopatadine Hydrochloride; Piperidines; Pyridines | 2019 |